EUVIMEDEUVIMED entdecken
Crossref

Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study

Journal of Oncology Research and Therapy · 16.03.2026 · 11 (1)

DOI: 10.29011/2574-710x.10335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Research and Therapy, online erschienen am 16.03.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study. Journal of Oncology Research and Therapy, 11(1). https://doi.org/10.29011/2574-710x.10335

Vancouver

Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study. Journal of Oncology Research and Therapy. 2026;11(1). doi:10.29011/2574-710x.10335

BibTeX
@article{euvimed2026,
  title = {Low-dose Chemotherapy, in Addition to Impacting Breast Cancer Metastasis, Establishes Immunomodulation: A Preclinical Study},
  journal = {Journal of Oncology Research and Therapy},
  year = {2026},
  volume = {11},
  number = {1},
  doi = {10.29011/2574-710x.10335}
}
Kostenlos starten →